Publications » 2011 » Conferences

Show per page  
131Klimaviciusa L.; Powell J.D.; Klegeris A.; Rumaks J.; Pupure J.; Svirskis S.; Plotniece A.; Pajuste K.; Klusa V. Paradoxical effects of the novel 1,4-dihydropyridine derivative: beneficial long-term effects in vivo, and acute toxicity in vitro. 40th Keystone III Symposia, Neurodegenerative Diseases: The Molecular and Cellular Basis for Neurodegeneration; February 21-26. P.216: Sagebrush Inn and Conference Center Taos, New Mexico, USA, 2011; 82.      

132Trapencieris P.; Zarina D.; Zalubovskis R.; Lends A.; Liepinsh E.; Marescu A.; Supuruan C. New selective Ca-I inhibitors. Session Lectures, 3rd International Conference on Drug Discovery and Therapy; February 7-10: SL-106. Dubai, UAE, 2011.      

133Skrivele B.; Pajuste K.; Hyvonen Z.; Ruponen M.; Pajuste Kl.; Kaldre D.; Cekavicus B.; Plotniece M.; Sobolev A.; Duburs G.; Plotniece A. Studies of self-assembling, gene delivery and antioxidant properties of polyfunctional pyridinium compounds on base of amphiphilic 1,4-dihydropyridine derivatives. Workshop of COST Action D43, European Cooperation in Science and Technology = COST; March 30th-April 1st: WG-P4. Madrid, Spain, 2011.      

134Makrecka M.; Kuka J.; Liepinsh E.; Maurina B. ; Dambrova M. The regulation of L-carnitine/carnitine palmitoyltransferase I system for cardioprotection. Abstract Book, 7th Leiden International Medical Student Conference; 16-20 March: Leiden, the Netherlands, 2011; 105.      

135Švalbe B.; Ošeniece B.; Muceniece R.; Zvejniece L. L-Karnitīna koncentrāciju samazinošā aģenta efekti išēmiska smadzeņu insulta eksperimentālajā modelī in vivo. Programma, Latvijas Universitātes 69. konference. Medicīnas sekcija; februārī - martā: Rīga, Latvija, 2011; 14.      

Show per page